We performed a meta-analysis of 11 studies with a total of 1398 patients with LSCC, in which TIL were quantified either immunohistochemically for CD8+, CD4+, and/or CD3+, or in HE-stained sections in tumor epithelium and/or tumor stroma. The gene discussed is CD8A; the disease is neoplasm.